ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER

被引:0
|
作者
Neri, G. [1 ,10 ]
Chiavelli, C. [1 ]
Trudu, L. [1 ,5 ,10 ]
Prapa, M. [1 ,2 ]
Golinelli, G. [1 ,3 ]
Pugliese, G. [1 ,4 ]
Silingardi, M. [1 ]
Rovesti, G. [1 ,5 ,10 ]
Grisendi, G. [1 ]
Bestagno, M. [6 ]
Spano, C. [7 ]
Benati, D. [8 ]
Recchia, A. [8 ]
Masciale, V. [1 ]
Bertolini, F. [5 ]
Dominici, M. [5 ,7 ,9 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy
[2] Univ Barleti, Dept Med Tech Sci, Tirana, Albania
[3] Univ Penn, Philadelphia, PA USA
[4] Leucid Bio Ltd, London, England
[5] Univ Hosp Modena, Div Oncol, Dept Oncol & Hematol, Modena, Italy
[6] Int Ctr Genet Engn & Biotechnol, Trieste, Friuli Venezia, Italy
[7] Evotec Modena Srl, Modena, Italy
[8] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Emilia Romagna, Italy
[9] Univ Modena & Reggio Emilia, Modena, Italy
[10] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Emilia Romagna, Italy
关键词
CAR T; SCLC; GD2;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
1067
引用
收藏
页码:S243 / S244
页数:2
相关论文
共 50 条
  • [21] TARGETING GLIOBLASTOMA & DIFFUSE INTRINSIC PONTINE GLIOMA W/ANTI-GD2 CAR MODIFIED NK CELLS
    Aggarwal, Payal
    Luo, Wen
    Pehlivan, Katherine
    Hoang, Hai
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S5 - S6
  • [22] Anti-GD2 CAR NKT Cells Are Safe and Produce Antitumor Responses in Patients with Relapsed/Refractory Neuroblastoma
    Heczey, Andras
    Courtney, Amy
    Ghatwai, Nisha
    Thakkar, Sachin
    Rathi, Purva
    Xu, Xin
    Ngai, Ho
    Di Piero, Erica J.
    Grilley, Bambi
    Sher, Andrew
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    MOLECULAR THERAPY, 2022, 30 (04) : 28 - 28
  • [23] Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas
    Zuo, Pengcheng
    Li, Yaopeng
    He, Chi
    Wang, Tantan
    Zheng, Xu
    Liu, Hao
    Wu, Zhen
    Zhang, Junting
    Liao, Xuebin
    Zhang, Liwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Anti-GD2 immunotherapy for neuroblastoma
    Sait, Sameer
    Modak, Shakeel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 889 - 904
  • [25] Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
    Mount, Christopher W.
    Majzner, Robbie G.
    Sundaresh, Shree
    Arnold, Evan P.
    Kadapakkam, Meena
    Haile, Samuel
    Labanieh, Louai
    Hulleman, Esther
    Woo, Pamelyn J.
    Rietberg, Skyler P.
    Vogel, Hannes
    Monje, Michelle
    Mackall, Crystal L.
    NATURE MEDICINE, 2018, 24 (05) : 572 - +
  • [26] Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
    Christopher W. Mount
    Robbie G. Majzner
    Shree Sundaresh
    Evan P. Arnold
    Meena Kadapakkam
    Samuel Haile
    Louai Labanieh
    Esther Hulleman
    Pamelyn J. Woo
    Skyler P. Rietberg
    Hannes Vogel
    Michelle Monje
    Crystal L. Mackall
    Nature Medicine, 2018, 24 : 572 - 579
  • [27] Anti-GD2 CAR T cells could prove transformative for H3-K27M+ diffuse midline gliomas
    Furukawa, Koichi
    Ohmi, Yuhsuke
    Furukawa, Keiko
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S87 - S93
  • [28] Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
    He Li
    Yao Huang
    Du-Qing Jiang
    Lian-Zhen Cui
    Zhou He
    Chao Wang
    Zhi-Wei Zhang
    Hai-Li Zhu
    Yong-Mei Ding
    Lin-Fang Li
    Qiang Li
    Hua-Jun Jin
    Qi-Jun Qian
    Cell Death & Disease, 9
  • [29] Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
    Li, He
    Huang, Yao
    Jiang, Du-Qing
    Cui, Lian-Zhen
    He, Zhou
    Wang, Chao
    Zhang, Zhi-Wei
    Zhu, Hai-Li
    Ding, Yong-Mei
    Li, Lin-Fang
    Li, Qiang
    Jin, Hua-Jun
    Qian, Qi-Jun
    CELL DEATH & DISEASE, 2018, 9
  • [30] ANTI-GD2 STRATEGY IN THE TREATMENT OF NEUROBLASTOMA
    Yang, R. K.
    Sondel, P. M.
    DRUGS OF THE FUTURE, 2010, 35 (08) : 665 - 673